Rajthanee Hospital Public (RJH.BK) Earnings Analysis
Rajthanee Hospital Public (RJH.BK) next reports earnings on 2026-08-10, consensus EPS 0.28 THB. Last quarter (2026-02-25) it beat with EPS 0.295 THB vs 0.28 THB est (+5.4%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 13.82.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RJH.BK next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | 0.28 THB |
| Revenue estimate | 0.70B |
RJH.BK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | 0.295 THB | 0.28 THB | +5.4% | Beat |
| 2025-08-13 | 0.2141 THB | n/a | n/a | n/a |
| 2025-05-12 | 0.21 THB | 0.33 THB | -36.4% | Miss |
| 2025-02-21 | 0.15 THB | 0.04 THB | +275% | Beat |
| 2024-11-11 | 0.71 THB | 0.48 THB | +47.9% | Beat |
| 2024-08-09 | 0.4 THB | 0.35 THB | +14.3% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
RJH.BK valuation and analyst view
| Trailing P/E | 13.82 |
|---|---|
| Trailing EPS | 1.098 THB |
| Price / book | 1.97 |
| Dividend yield | 3.95% |
| Market cap | 4.46B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Rajthanee Hospital Public (RJH.BK)'s next earnings date?
Rajthanee Hospital Public is next scheduled to report on 2026-08-10, with a consensus EPS estimate of 0.28 THB and revenue estimate of 0.70B.
Did RJH.BK beat earnings last quarter?
In its 2026-02-25 report, RJH.BK posted EPS of 0.295 THB versus a 0.28 THB estimate — a beat of 5.4%.
What is RJH.BK's earnings track record?
Over the last 5 reported quarters with consensus data, RJH.BK beat estimates 4 times (80%).
What is RJH.BK's current P/E ratio and EPS?
RJH.BK trades at a trailing P/E of 13.82 on trailing EPS of 1.097603139582627 THB.
What do analysts rate RJH.BK?
RJH.BK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.